Literature DB >> 17005196

Opposing cardiovascular roles for the angiotensin and apelin signaling pathways.

Euan Ashley, Hyung J Chun, Thomas Quertermous.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17005196     DOI： 10.1016/j.yjmcc.2006.08.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  15 in total

1.  Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver.

Authors:  Hiroaki Yokomori; Masaya Oda; Kazunori Yoshimura; Sanae Machida; Fumihiko Kaneko; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2010-08-20       Impact factor: 7.527

2.  The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition.

Authors:  K Siddiquee; J Hampton; D McAnally; Lt May; Lh Smith
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

3.  Ontogeny of apelin and its receptor in the rodent gastrointestinal tract.

Authors:  Guiyun Wang; Ramendra Kundu; Song Han; Xiang Qi; Ella W Englander; Thomas Quertermous; George H Greeley
Journal:  Regul Pept       Date:  2009-08-04

4.  Investigation of changes in apelin receptor mRNA and protein expression in the myocardium and aorta of rats with two-kidney, one-clip (2K1C) Goldblatt hypertension.

Authors:  Hamid Najafipour; Abedin Vakili; Beydolah Shahouzehi; Ava Soltani Hekmat; Yaser Masoomi; Mahbobeh Yeganeh Hajahmadi; Saeed Esmaeli-Mahani
Journal:  J Physiol Biochem       Date:  2015-02-25       Impact factor: 4.158

5.  Increased bone mass in mice lacking the adipokine apelin.

Authors:  Lalita Wattanachanya; Wei-Dar Lu; Ramendra K Kundu; Liping Wang; Marcia J Abbott; Dylan O'Carroll; Thomas Quertermous; Robert A Nissenson
Journal:  Endocrinology       Date:  2013-04-12       Impact factor: 4.736

6.  Apelin-APJ signaling in retinal angiogenesis.

Authors:  Yoko Kojima; Thomas Quertermous
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10       Impact factor: 8.311

7.  Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition.

Authors:  Victoria N Parikh; Jing Liu; Ching Shang; Christopher Woods; Alex C Chang; Mingming Zhao; David N Charo; Zachary Grunwald; Yong Huang; Kinya Seo; Philip S Tsao; Daniel Bernstein; Pilar Ruiz-Lozano; Thomas Quertermous; Euan A Ashley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

8.  In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.

Authors:  Ahmad Y Sheikh; Hyung J Chun; Alexander J Glassford; Ramendera K Kundu; Ingo Kutschka; Diego Ardigo; Stephen L Hendry; Roger A Wagner; Mary M Chen; Ziad A Ali; Patrick Yue; Diem T Huynh; Andrew J Connolly; Marc P Pelletier; Philip S Tsao; Robert C Robbins; Thomas Quertermous
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-28       Impact factor: 4.733

9.  Cardiovascular response to small-molecule APJ activation.

Authors:  Brandon Ason; Yinhong Chen; Qi Guo; Kimberly M Hoagland; Ray W Chui; Mark Fielden; Weston Sutherland; Rhonda Chen; Ying Zhang; Shirley Mihardja; Xiaochuan Ma; Xun Li; Yaping Sun; Dongming Liu; Khanh Nguyen; Jinghong Wang; Ning Li; Sridharan Rajamani; Yusheng Qu; BaoXi Gao; Andrea Boden; Vishnu Chintalgattu; Jim R Turk; Joyce Chan; Liaoyuan A Hu; Paul Dransfield; Jonathan Houze; Jingman Wong; Ji Ma; Vatee Pattaropong; Murielle M Véniant; Hugo M Vargas; Gayathri Swaminath; Aarif Y Khakoo
Journal:  JCI Insight       Date:  2020-04-23

10.  Apelin retards the progression of diabetic nephropathy.

Authors:  Robert T Day; Rita C Cavaglieri; Denis Feliers
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.